Labetalol Monograph
Introduction Labetalol is a non-selective beta‑adrenergic antagonist with additional alpha‑1 blocking activity. It is commonly employed in the management of hypertension, particularly during acute hypertensive emergencies, and in certain forms of arrhythmia. The drug exhibits a unique pharmacologic profile that allows for both reduction of cardiac output and vasodilation, thereby providing a balanced cardiovascular effect….